Evidence map›Paper›PMID 24357669›Full record

ArticleJournal of the American Society of Nephrology : JASN2014

Estimating podocyte number and density using a single histologic section.

Madhusudan Venkatareddy, Su Wang, Yan Yang, Sanjeevkumar Patel, Larysa Wickman, Ryuzoh Nishizono, Mahboob Chowdhury, Jeffrey Hodgin, Paul A Wiggins, Roger C Wiggins

Open access · bronzeAbstract readValidation Study
In one paragraph

Article in Journal of the American Society of Nephrology : JASN, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 108 papers.

0numbers the graph read from it
0cells of the map it votes in
108citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

108 citing papers in PubMed, 140 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Effects of Prothrombin on Podocytopathy and Proteinuria in Glomerular Disease.Journal of the American Society of Nephrology : JASN · 2025
    Article

48 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Madhusudan VenkatareddyDepartments of Internal Medicine.
Su WangDepartments of Internal Medicine.
Yan YangDepartments of Internal Medicine.
Sanjeevkumar PatelDepartments of Internal Medicine.
Larysa WickmanPediatrics and Communicable Diseases, and.
Ryuzoh NishizonoDepartments of Internal Medicine.
Mahboob ChowdhuryDepartments of Internal Medicine.
Jeffrey HodginPathology, University of Michigan, Ann Arbor, Michigan; and.
Paul A WigginsDepartment of Physics and Department of Bioengineering, University of Washington, Seattle, Washington.
Roger C WigginsDepartments of Internal Medicine, rwiggins@umich.edu.
University of Michigan–Ann Arbor · USCenter for Non-Communicable Diseases · PKUniversity of Washington · US

Funding

XenograftP30CA046592 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Eric R. Fearon · 1988 to 2026
$178.2M
University of Michigan O'Brien Kidney Translational Core CenterP30DK081943 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PENNATHUR, SUBRAMANIAM · 2008 to 2022
$12.9M
The Glomerular PodocyteR01DK046073 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI WIGGINS, ROGER CHARLES · 1993 to 2015
$4.7M
NCI NIH HHS 5 P30 CA46592NCI NIH HHS P30 CA046592NIDDK NIH HHS P30 DK081943NIDDK NIH HHS R01 DK046073NIDDK NIH HHS R01-DK46073
6 · The paper itself

Abstract

The reduction in podocyte density to levels below a threshold value drives glomerulosclerosis and progression to ESRD. However, technical demands prohibit high-throughput application of conventional morphometry for estimating podocyte density. We evaluated a method for estimating podocyte density using single paraffin-embedded formalin-fixed sections. Podocyte nuclei were imaged using indirect immunofluorescence detection of antibodies against Wilms' tumor-1 or transducin-like enhancer of split 4. To account for the large size of podocyte nuclei in relation to section thickness, we derived a correction factor given by the equation CF=1/(D/T+1), where T is the tissue section thickness and D is the mean caliper diameter of podocyte nuclei. Normal values for D were directly measured in thick tissue sections and in 3- to 5-μm sections using calibrated imaging software. D values were larger for human podocyte nuclei than for rat or mouse nuclei (P<0.01). In addition, D did not vary significantly between human kidney biopsies at the time of transplantation, 3-6 months after transplantation, or with podocyte depletion associated with transplant glomerulopathy. In rat models, D values also did not vary with podocyte depletion, but increased approximately 10% with old age and in postnephrectomy kidney hypertrophy. A spreadsheet with embedded formulas was created to facilitate individualized podocyte density estimation upon input of measured values. The correction factor method was validated by comparison with other methods, and provided data comparable with prior data for normal human kidney transplant donors. This method for estimating podocyte density is applicable to high-throughput laboratory and clinical use.

Indexed as

Fluorescent Antibody Technique, IndirectAnimalsBiopsyCell CountFemaleHumansMaleMiceNuclear ProteinsPodocytesRatsReference StandardsRepressor ProteinsSpecimen HandlingWT1 ProteinsNuclear ProteinsRepressor ProteinsTLE4 protein, humanWT1 Proteins

Identifiers

PMID24357669
PMCPMC4005315
OpenAlexW2155587088

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.